Mainz Biomed NV
MYNZ1.382USD
+0.052+3.90%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
3.21MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Mainz Biomed NV Unternehmen
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Unternehmensinformationen
BörsenkürzelMYNZ
Name des UnternehmensMainz Biomed NV
IPO-datumNov 04, 2021
CEOMr. Guido Baechler
Anzahl der mitarbeiter19
WertpapierartOrdinary Share
GeschäftsjahresendeNov 04
AddresseSirius Gutenberg Park
StadtMAINZ
BörseNASDAQ Capital Market Consolidated
LandGermany
Postleitzahl55129
Telefon4961315542860
Websitehttps://www.mainzbiomed.com/
BörsenkürzelMYNZ
IPO-datumNov 04, 2021
CEOMr. Guido Baechler
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
20.06K
+6.65%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
17.77K
-0.84%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+1379.29%
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
2.20K
--
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
20.06K
+6.65%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
17.77K
-0.84%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+1379.29%
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
2.20K
--
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, May 16
Aktualisiert: Fri, May 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Armistice Capital LLC
5.15%
Fur Wiederaufbau (Kredianstalt)
0.61%
Morgan Stanley & Co. LLC
0.58%
Baechler (Guido)
0.53%
Hekland (Hans)
0.47%
Other
92.66%
Aktionäre
Aktionäre
Anteil
Armistice Capital LLC
5.15%
Fur Wiederaufbau (Kredianstalt)
0.61%
Morgan Stanley & Co. LLC
0.58%
Baechler (Guido)
0.53%
Hekland (Hans)
0.47%
Other
92.66%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
5.15%
Individual Investor
1.95%
Research Firm
0.85%
Investment Advisor
0.13%
Other
91.92%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
34
308.42K
8.08%
-19.73K
2025Q1
40
350.55K
9.90%
-3.02K
2024Q4
40
356.23K
16.03%
+257.88K
2024Q3
37
115.45K
5.70%
+19.26K
2024Q2
34
120.95K
9.96%
+24.53K
2024Q1
36
122.04K
10.26%
+25.33K
2023Q4
27
96.56K
23.08%
+9.46K
2023Q3
22
91.42K
24.64%
+4.27K
2023Q2
22
91.39K
24.65%
+4.22K
2023Q1
19
86.84K
24.47%
+12.12K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Armistice Capital LLC
196.60K
5.15%
-25.40K
-11.44%
Mar 31, 2025
Fur Wiederaufbau (Kredianstalt)
23.20K
0.61%
-7.74K
-25.00%
Sep 30, 2024
Morgan Stanley & Co. LLC
22.20K
0.58%
+22.20K
--
Mar 31, 2025
Baechler (Guido)
20.06K
0.53%
+1.25K
+6.65%
Mar 21, 2025
Hekland (Hans)
17.77K
0.47%
-151.00
-0.84%
Mar 21, 2025
Virtu Americas LLC
10.23K
0.27%
-8.10K
-44.17%
Mar 31, 2025
Caragol (William J)
7.90K
0.21%
+2.58K
+48.56%
Mar 21, 2025
von Toerne (Chris)
2.50K
0.07%
+2.33K
+1379.29%
Mar 21, 2025
Dreismann (Heiner)
2.20K
0.06%
--
--
Mar 21, 2025
UBS Financial Services, Inc.
1.91K
0.05%
-1.85K
-49.20%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Nov 29, 2024
Merger
40<1
Nov 29, 2024
Merger
40<1
Nov 29, 2024
Merger
40<1
Nov 29, 2024
Merger
40<1
Datum
Art
Verhältnis
Nov 29, 2024
Merger
40<1
Nov 29, 2024
Merger
40<1
Nov 29, 2024
Merger
40<1
Nov 29, 2024
Merger
40<1
